C.M. Bidwell & Associates’s LeMaitre Vascular LMAT Stock Holding History

C.M. Bidwell & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,695	Closed	-$196K	–	598
2021 Q3	$196K	Sell	3,695 -1,535	-29%	-$86.5K	0.13%	154
2021 Q2	$319K	Buy	+5,230	New	+$278K	0.21%	81
2020 Q1	–	Sell	-1,975	Closed	-$71K	–	414
2019 Q4	$71K	Sell	1,975 -325	-14%	-$11.2K	0.06%	187
2019 Q3	$79K	Buy	+2,300	New	+$73.5K	0.08%	203
2017 Q4	–	Sell	-7,670	Closed	-$287K	–	424
2017 Q3	$287K	Buy	+7,670	New	+$261K	0.44%	88
2017 Q1	–	Sell	-4,370	Closed	-$111K	–	268
2016 Q4	$111K	Buy	+4,370	New	+$97K	0.03%	196

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

C.M. Bidwell & Associates's LMAT Position: Q4 2021 in Review

C.M. Bidwell & Associates sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 3,695 shares — an estimated $196K sold.

C.M. Bidwell & Associates first reported a position in LMAT in Q4 2016 and held it in 6 quarters. The position peaked at $319K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

C.M. Bidwell & Associates reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
C.M. Bidwell & Associates sold 3,695 LeMaitre Vascular shares in Q4 2021, an estimated $196K.
C.M. Bidwell & Associates first reported a position in LeMaitre Vascular in Q4 2016 and held it in 6 quarters.
C.M. Bidwell & Associates's LeMaitre Vascular position peaked at $319K in Q2 2021.
183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.